# CBD And CBG From Cannabis May Help Treat Liver Condition > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cbd-cbg-preclinical-research-nafld-cannabis-liver-study/ > **Published:** 2026-03-23T12:03:02-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:41:39-04:00 > **Clinical Summary:** Explore CBD CBG preclinical research NAFLD showing cannabis compounds' potential to treat fatty liver disease and improve liver health. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Liver DiseaseCbdCbgPreclinical ResearchNafld Why This Matters Non-alcoholic [fatty liver disease](https://cedclinic.com/cannabinoid-receptor-type-1-antagonist-obesity-steatohepatitis/) affects nearly 25% of US adults and has limited therapeutic options. If [cannabis compounds](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/) demonstrate hepatoprotective effects, this could represent a significant advancement in managing a condition that can progress to cirrhosis and liver failure. Clinical Summary Preclinical research suggests CBD and CBG may have therapeutic potential for non-alcoholic [fatty liver disease](https://cedclinic.com/cannabinoid-receptor-type-1-antagonist-obesity-steatohepatitis/) (NAFLD) through anti-inflammatory and metabolic pathways. The compounds appear to reduce hepatic steatosis and inflammation in laboratory models, though the specific mechanisms remain under investigation. No human [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) have been completed to establish safety, efficacy, or appropriate dosing for NAFLD treatment. Current evidence is limited to in vitro and animal studies. Dr. Caplan’s Take “While the preclinical data is intriguing, we’re years away from knowing if [cannabis compounds](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/) can safely and effectively treat NAFLD in humans. Patients should not delay proven lifestyle interventions while waiting for [cannabis-based therapies](https://cedclinic.com/cannabinoids-inhibit-keratinocyte-proliferation-non-cb1-cb2/) to be validated.” Clinical Perspective 🧠 Clinicians should continue recommending evidence-based NAFLD management including weight loss, exercise, and metabolic optimization. Cannabis compounds remain investigational for liver disease, and patients using cannabis products should have regular liver function monitoring. Any therapeutic claims for NAFLD treatment are premature without human clinical data. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20CBD%20And%20CBG%20From%20The%20Cannabis%20Plant%20Could%20Help%20Treat%20A%20Common%20Liver%20Condition%20%7C%20...%20%40drcaplan&url=https%3A//www.iflscience.com/cannabis-compounds-could-help-treat-a-common-liver-condition-that-affects-nearly-a-quarter-of-us-adults-82929)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.iflscience.com/cannabis-compounds-could-help-treat-a-common-liver-condition-that-affects-nearly-a-quarter-of-us-adults-82929)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20CBD%20And%20CBG%20From%20The%20Cannabis%20Plant%20Could%20Help%20Treat%20A%20Common%20Liver%20Condition%20%7C%20...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.iflscience.com/cannabis-compounds-could-help-treat-a-common-liver-condition-that-affects-nearly-a-quarter-of-us-adults-82929)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.iflscience.com/cannabis-compounds-could-help-treat-a-common-liver-condition-that-affects-nearly-a-quarter-of-us-adults-82929](https://www.iflscience.com/cannabis-compounds-could-help-treat-a-common-liver-condition-that-affects-nearly-a-quarter-of-us-adults-82929) Table of Contents - [FAQ](#FAQ)[What cannabinoids were studied in relation to liver disease?](#What_cannabinoids_were_studied_in_relation_to_liver_disease) - [What type of study was conducted?](#What_type_of_study_was_conducted) - [Why is this research considered clinically relevant?](#Why_is_this_research_considered_clinically_relevant) - [What liver conditions might benefit from cannabinoid treatment?](#What_liver_conditions_might_benefit_from_cannabinoid_treatment) - [What are the next steps for this research?](#What_are_the_next_steps_for_this_research) - [Related](#Related) ## FAQ #### What cannabinoids were studied in relation to liver disease? The research focused on CBD (cannabidiol) and CBG (cannabigerol), two non-psychoactive compounds found in cannabis. These cannabinoids were investigated for their potential therapeutic effects on liver conditions. #### What type of study was conducted? This was preclinical research, meaning the studies were conducted in laboratory settings using cell cultures or animal models. These studies provide preliminary data before potential human [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/). #### Why is this research considered clinically relevant? The findings received a clinical relevance rating of #70, indicating “Notable Clinical Interest.” This suggests the research presents emerging findings that are worth monitoring closely for potential clinical applications. #### What liver conditions might benefit from cannabinoid treatment? While specific conditions aren’t detailed in the summary, the research appears to focus on general liver disease applications. The study likely examined how CBD and CBG might protect liver cells or reduce inflammation in liver tissue. #### What are the next steps for this research? As preclinical research, these findings would need to be validated through human clinical trials before any therapeutic applications could be considered. The current stage represents early-phase investigation into cannabinoids’ potential liver-protective properties. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “CBD And CBG From The Cannabis Plant Could Help Treat A Common Liver Condition | IFLScience”, “url”: “https://www.iflscience.com/cannabis-compounds-could-help-treat-a-common-liver-condition-that-affects-nearly-a-quarter-of-us-adults-82929”, “datePublished”: “2026-03-23T12:59:50Z”, “about”: “cbd cbg cannabis plant could help”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Study Finds Cannabis Compounds May Help Reduce Fatty Liver Disease](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) This study explores how cannabis compounds might reduce fatty liver disease, supporting the potential benefits of cannabinoids for liver health. [Read Study](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) [Two compounds found in cannabis plant reverse liver disease damage, study suggests](https://cedclinic.com/cannabis-compounds-reverse-liver-damage-study/) Research indicates that cannabis compounds may reverse liver damage, highlighting the therapeutic promise of CBD and CBG. [Learn More](https://cedclinic.com/cannabis-compounds-reverse-liver-damage-study/) [New research suggests cannabinoids like CBD and CBG may help improve fatty liver disease.](https://cedclinic.com/cannabinoids-fatty-liver-clinical-relevance/) Recent findings suggest cannabinoids such as CBD and CBG could improve fatty liver disease outcomes through [anti-inflammatory effects](https://cedclinic.com/cbd-antioxidative-anti-inflammatory-properties-benefits/). [Explore Research](https://cedclinic.com/cannabinoids-fatty-liver-clinical-relevance/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).